Table 3.
Individual tumour–methylation patterns
| Gene | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Tumour type and number | OPCML | CTNNG | HOX9A | EMP3 | SYK | HSP47(A) | HSP47 (B) | TMS1 | MI |
| PV 03 | U | U | U | U | U | U | M | U | 0.125 |
| PV 04 | U | U | U | U | U | M | M | U | 0.25 |
| PV 05 | U | U | M | U | U | M | M | U | 0.375 |
| PV 06 | U | U | U | U | U | U | U | U | 0 |
| PV 07 | U | U | U | U | U | U | M | U | 0.125 |
| PV 08 | U | U | U | U | U | U | U | U | 0 |
| PV 09 | U | U | U | U | U | M | M | U | 0.25 |
| PV 10 | U | U | U | U | U | M | M | U | 0.25 |
| PV 11 | U | U | ND | U | ND | U | U | ND | 0 |
| PV 12 | U | U | ND | U | ND | M | M | ND | 0.25 |
| PV 13 | U | U | M | U | U | U | U | U | 0.125 |
| PV 15 | U | U | U | U | U | U | U | U | 0 |
| PV 16 | U | U | U | U | U | M | M | U | 0.25 |
| PV 17 | U | U | M | U | U | U | U | U | 0.125 |
| PV 18 | U | U | U | U | U | U | U | U | 0 |
| PV 19 | M | U | U | U | U | U | U | U | 0.125 |
| PV 21 | U | U | M | U | U | U | U | U | 0.125 |
| PV 22 | M | U | ND | U | ND | U | M | ND | 0.25 |
| PV 23 | U | U | U | M | U | M | M | U | 0.375 |
| PS 03 | U | M | M | M | U | M | M | M | 0.75 |
| PS 05 | M | U | U | U | U | U | U | U | 0.125 |
| PS 06 | M | U | U | U | U | M | M | U | 0.375 |
| PS 07 | U | U | U | U | U | U | U | M | 0.125 |
| PS 08 | U | U | U | U | U | U | U | U | 0 |
| PS 09 | U | U | U | U | U | U | M | U | 0.125 |
| PS 11 | U | U | ND | U | ND | U | U | ND | 0 |
| PS 12 | U | U | U | U | U | M | M | U | 0.25 |
| PS 13 | U | U | U | U | U | U | U | U | 0 |
| PS 14 | U | U | U | U | U | U | U | U | 0 |
| PS 15 | U | U | U | U | U | M | M | U | 0.25 |
| PS 16 | U | U | U | U | U | M | M | U | 0.25 |
| PS 17 | U | U | U | U | U | U | M | U | 0.125 |
| PS 18 | U | U | U | U | U | U | U | U | 0 |
| NB 01 | U | U | M | M | M | M | ND | 0.67 | |
| NB 03 | U | M | U | U | U | U | M | U | 0.25 |
| NB 04 | U | U | U | U | U | U | M | U | 0.125 |
| NB 05 | U | U | U | U | U | U | M | U | 0.125 |
| NB 06 | U | U | M | M | U | M | M | U | 0.5 |
| NB 07 | U | U | U | M | U | M | M | M | 0.375 |
| NB 08 | U | U | U | U | U | U | U | U | 0 |
| NB 09 | U | U | U | M | U | M | M | U | 0.375 |
| NB 10 | U | U | U | M | U | M | M | U | 0.375 |
| NB 11 | M | U | U | M | U | M | M | U | 0.5 |
| NB 12 | U | M | U | U | U | U | M | U | 0.25 |
| NB 13 | U | U | U | M | U | M | M | U | 0.375 |
| NB 14 | U | U | U | M | U | M | M | U | 0.375 |
| NB 15 | U | U | U | M | U | M | M | U | 0.375 |
| NB 16 | U | U | U | M | U | M | M | U | 0.375 |
| NB 17 | U | U | M | M | U | M | M | M | 0.625 |
| NB 18 | U | U | M | M | U | M | M | M | 0.625 |
| NB 19 | U | U | U | U | U | U | U | U | 0 |
| NB 20 | M | U | ND | M | ND | M | M | ND | 0.8 |
NB, neuroblastoma; PS, sporadic phaeochromocytoma; PV, VHL, associated phaeochromocytoma; U, unmethylated; M, methylated; ND, not determined (failed); MI, methylation index (number of methylated genes/number genes analysed).